AtriCure Short Long Term Debt Total from 2010 to 2024
ATRC Stock | USD 20.89 1.33 5.99% |
Short and Long Term Debt Total | First Reported 2005-09-30 | Previous Quarter 74.4 M | Current Value 74.5 M | Quarterly Volatility 30.3 M |
Check AtriCure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AtriCure main balance sheet or income statement drivers, such as Interest Expense of 7.3 M, Total Revenue of 419.2 M or Gross Profit of 312.3 M, as well as many exotic indicators such as Price To Sales Ratio of 3.93, Dividend Yield of 0.0081 or PTB Ratio of 3.76. AtriCure financial statements analysis is a perfect complement when working with AtriCure Valuation or Volatility modules.
AtriCure | Short Long Term Debt Total |
Latest AtriCure's Short Long Term Debt Total Growth Pattern
Below is the plot of the Short Long Term Debt Total of AtriCure over the last few years. It is AtriCure's Short and Long Term Debt Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AtriCure's overall financial position and show how it may be relating to other accounts over time.
Short Long Term Debt Total | 10 Years Trend |
|
Short Long Term Debt Total |
Timeline |
AtriCure Short Long Term Debt Total Regression Statistics
Arithmetic Mean | 41,179,019 | |
Geometric Mean | 23,605,629 | |
Coefficient Of Variation | 77.02 | |
Mean Deviation | 28,275,409 | |
Median | 38,893,000 | |
Standard Deviation | 31,714,304 | |
Sample Variance | 1005.8T | |
Range | 76.7M | |
R-Value | 0.94 | |
Mean Square Error | 119.2T | |
R-Squared | 0.89 | |
Slope | 6,690,094 | |
Total Sum of Squares | 14081.2T |
AtriCure Short Long Term Debt Total History
About AtriCure Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include AtriCure income statement, its balance sheet, and the statement of cash flows. AtriCure investors use historical funamental indicators, such as AtriCure's Short Long Term Debt Total, to determine how well the company is positioned to perform in the future. Although AtriCure investors may use each financial statement separately, they are all related. The changes in AtriCure's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AtriCure's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on AtriCure Financial Statements. Understanding these patterns can help to make the right decision on long term investment in AtriCure. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Short and Long Term Debt Total | 74.5 M | 78.2 M |
Pair Trading with AtriCure
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AtriCure position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AtriCure will appreciate offsetting losses from the drop in the long position's value.Moving against AtriCure Stock
0.84 | INSP | Inspire Medical Systems Financial Report 7th of May 2024 | PairCorr |
0.81 | EHC | Encompass Health Corp | PairCorr |
0.76 | GKOS | Glaukos Corp | PairCorr |
0.69 | BSX | Boston Scientific Corp | PairCorr |
0.48 | DXCM | DexCom Inc | PairCorr |
The ability to find closely correlated positions to AtriCure could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AtriCure when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AtriCure - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AtriCure to buy it.
The correlation of AtriCure is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AtriCure moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AtriCure moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AtriCure can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of AtriCure Correlation against competitors. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for AtriCure Stock analysis
When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Is AtriCure's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Revenue Per Share 8.923 | Quarterly Revenue Growth 0.164 | Return On Assets (0.04) | Return On Equity (0.08) |
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.